| 2017-07 | Engineering of multifunctional temperature-sensitive liposomes for synergistic photothermal, photodynamic, and chemotherapeutic effects | 최한곤 |
| 2006-09 | Enhanced anti-tumor activity and alleviated hepatotoxicity of clotrimazole-loaded suppository using poloxamer-propylene glycol gel | 최한곤 |
| 2007-02 | Enhanced bioavailability of poorly water-soluble clotrimazole by inclusion with beta-cyclodextrin | 최한곤 |
| 2020-01 | Enhanced chemical stability of D-cycloserine via tablet form containing magnesium oxide as an alkali stabilizer | 최한곤 |
| 2008-11 | Enhanced Dissolution of Ibuprofen Using Solid Dispersion with Poloxamer 407 | 최한곤 |
| 2008-10 | Enhanced dissolution of ibuprofen using solid dispersion with polyethylene glycol 20000 | 최한곤 |
| 2004-10 | Enhanced mucosal and systemic immunogenicity of human papillomavirus-like particles encapsidating interleukin-2 gene adjuvant | 최한곤 |
| 2009-05 | Enhanced oral bioavailability of Coenzyme Q(10) by self-emulsifying drug delivery systems | 최한곤 |
| 2009-06 | Enhanced oral bioavailability of Coenzyme Q(10) by self-emulsifying drug delivery systems | 최한곤 |
| 2009-07 | Enhanced oral bioavailability of dexibuprofen by a novel solid Self-emulsifying drug delivery system (SEDDS) | 최한곤 |
| 2009-08 | Enhanced oral bioavailability of dexibuprofen by a novel solid Self-emulsifying drug delivery system (SEDDS) | 최한곤 |
| 2015-03 | Enhanced oral bioavailability of fenofibrate using polymeric nanoparticulated systems: physicochemical characterization and in vivo investigation | 최한곤 |
| 2005-08 | Enhanced oral bioavailability of ibuprofen in rats by poloxamer gel using poloxamer 188 and menthol | 최한곤 |
| 2007-04 | Enhanced oral bioavailability of piroxicam in rats by hyaluronate microspheres | 최한곤 |
| 2004-11 | Enhanced rectal bioavailability of ibuprofen in rats by poloxamer 188 and menthol | 최한곤 |
| 2008-04 | Enhancement of solubility, dissolution and Bioavailability of ibuprofen in solid dispersion systems | 최한곤 |
| 2004-03 | Erythrocyte ghost-mediated gene delivery for prolonged and blood-targeted expression | 최한곤 |
| 2007-11 | Evaluation of physicochemical properties, skin permeation and accumulation profiles of ketorolac fatty ester prodrugs | 최한곤 |
| 2008-02 | Evaluation of skin permeation and accumulation profiles of a highly lipophilic fatty ester | 최한곤 |
| 2007-10 | Evaluation of skin permeation and accumulation profiles of ketorolac fatty esters | 최한곤 |
| 2007-05 | Expression, purification, and antibody binding activity of human papillomavirus 16 L1 protein fused to maltose binding protein | 최한곤 |
| 2017-10 | Facile construction of bioreducible crosslinked polypeptide micelles for enhanced cancer combination therapy | 최한곤 |
| 2018-11 | Facile fabrication of highly photothermal-effective albumin-assisted gold nanoclusters for treating breast cancer | 최한곤 |
| 2015-10 | Facile one-pot formulation of TRAIL-embedded paclitaxel-bound albumin nanoparticles for the treatment of pancreatic cancer | 최한곤 |
| 2018-07 | Folate receptor-mediated celastrol and irinotecan combination delivery using liposomes for effective chemotherapy | 최한곤 |
| 2017-04 | Folate receptor-targeted hybrid lipid-core nanocapsules for sequential delivery of doxorubicin and tanespimycin | 최한곤 |
| 2016-10 | Folate-Mediated Targeted Delivery of Combination Chemotherapeutics Loaded Reduced Graphene Oxide for Synergistic Chemo-Photothermal Therapy of Cancers | 최한곤 |
| 2019-01 | Folate-targeted nanostructured chitosan/chondroitin sulfate complex carriers for enhanced delivery of bortezomib to colorectal cancer cells | 최한곤 |
| 2009-06 | Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery | 최한곤 |
| 2009-06 | Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery | 최한곤 |
